Table 2 Results summary of ultrasound findings before (baseline) and after running (follow-up)
Baseline follow | Up p | Baseline follow | |
|---|---|---|---|
Knee joints with suprapatellar effusion (%) | 105 (50.0) | 100 (47.6) | 0.696 |
Mean amount of suprapatellar effusion (mm with SD) | 15.5 ± 17.0 | 13.9 ± 15.9 | 0.151 |
Knee joint baseline-to-follow-up comparison (%) | |||
unchanged joint finding at follow-up | 140 (66.7) | ||
deteriorated joint finding at follow-up | 32 (15.2) | ||
improved joint finding at follow-up | 38 (18.1) | ||
Prevalence of patellar tendon hypervascularity (%) | 1 (0.5) | 21 (10.0) | < 0.001 |
Talocrural joints with effusion (%) | 38 (18.1) | 33 (15.7) | 0.603 |
Mean amount of talocrural effusion (mm with SD) | 5.2 ± 11.8 | 4.7 ± 11.6 | 0.565 |
Talocrural joint baseline-to-follow-up comparison (%) | |||
unchanged joint finding at follow-up | 173 (82.3) | ||
deteriorated joint finding at follow-up | 15 (7.2) | ||
improved joint finding at follow-up | 22 (10.5) |